findmyKOL
Clinical trialNCT06281236TerminatedPhase 1Interventional

A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)

SponsorSparrow PharmaceuticalsEnrollment1Polymyalgia Rheumatica
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This will be an open label phase 1b trial to characterize the pharmacodynamics and PK of prednisolone and SPI-62 when co-administered to participants with PMR. Up to 24 participants could be recruited.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Emovis Gmbh

    Berlin, Germany

  • Klinische Forschung Hannover Mitte Gmbh/pratia

    Hanover, Germany

  • Universitätsmedizin Der Johannes Gutenburg Universität Mainz

    Mainz, Germany

  • Klinikum Der Universität München

    München, Germany

  • Klinische Forschung Schwerin Gmbh/pratia

    Schwerin, Germany

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Prednisolone →SPI-62
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Feb 2022
Primary completion
25 Mar 2025
Completion
25 Apr 2025
Last update posted
16 May 2025
Registered enrollment
1
Registry id
NCT06281236
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.